icon-folder.gif   Conference Reports for NATAP  
 
  59th Annual Meeting of the American Association
for the Study of Liver Diseases
(AASLD)
Oct 31-Nov 1 2008
San Francisco, CA
Back grey_arrow_rt.gif
 
 
 
Viral Responses in African Americans, Latinos, and Caucasians in the US Phase 2 Study (PROVE1) of Telaprevir with Peginterferon Alfa-2a and Ribavirin in Treatment-Naïve, Genotype 1-Infected Patients with Hepatitis C
 
 
  AASLD 2008 SF
 
Reported by Jules Levin
 
Andrew J Muir,1 Eric J Lawitz,2 John G McHutchison,1 Stuart C Gordon,3 Ira M Jacobson,4 Bambang S Adiwijaya,5 Leif Bengtsson,5 Lindsay McNair,5 Maribel Rodriguez-Torres6
 
1Duke Clinical Research Institute, Durham, NC, USA; 2Alamo Medical Research, San Antonio, TX, USA; 3Henry Ford Hospital, Detroit, MI, USA; 4Weill Medical College of Cornell University, New York, NY, USA; 5Vertex Pharmaceuticals Incorporated, Boston, MA, USA; 6Fundacion de Investigacion de Diego, Ponce School of Medicine, San Juan, Puerto Rico
 

summ-1.gif

cons-2.gif

back-3.gif

Methos-4.gif

race-5.gif

result-6.gif

Tpr-7.gif

RVR-8.gif

recdent-9.gif

africn-10.gif

Dyn-11.gif

events-12.gif

REfer-13.gif